Biomarkers in Enteropathic Arthritis
Open Access
- 4 June 2020
- journal article
- Published by Heighten Science Publications Corporation in Annals of Clinical Gastroenterology and Hepatology
- Vol. 4 (1), 039-044
- https://doi.org/10.29328/journal.acgh.1001021
Abstract
Inflammatory Bowel Disease (IBD)-associated arthritis is called Enteropathic Arthritis (EA) which is classified among the group of Spondyloarthritis (SpA), because its presentation is variable.Keywords
This publication has 41 references indexed in Scilit:
- Serologic Markers: Impact on Early Diagnosis and Disease Stratification in Inflammatory Bowel DiseasePostgraduate Medicine, 2010
- The diagnostic utility of magnetic resonance imaging in spondylarthritis: An international multicenter evaluation of one hundred eighty‐seven subjectsArthritis & Rheumatism, 2010
- Autoantibodies pANCA, GAB and PAB in inflammatory bowel disease: prevalence, characteristics and diagnostic valueWiener klinische Wochenschrift, 2010
- Hepatosplenic T-cell lymphoma in a patient with Crohn's diseaseNature Reviews Gastroenterology & Hepatology, 2009
- Serologic Investigations in Children with Inflammatory Bowel Disease and Food AllergyMediators of Inflammation, 2009
- Calprotectina fecal como marcador diferencial entre patología gastrointestinal orgánica y funcionalRevista Española de Enfermedades Digestivas, 2007
- Serologic Markers in Inflammatory Bowel DiseaseClinical Chemistry, 2006
- Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel diseaseScandinavian Journal of Gastroenterology, 2006
- Infliximab for Induction and Maintenance Therapy for Ulcerative ColitisThe New England Journal of Medicine, 2005
- Maintenance infliximab for Crohn's disease: the ACCENT I randomised trialThe Lancet, 2002